Evidence map›Paper›PMID 36371538›Full record

ArticleScientific reports2022

An optical and electrochemical sensor based on L-arginine functionalized reduced graphene oxide.

Sanaz Ghanbari, Fatemeh Ahour, Sajjad Keshipour

Abstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sanaz GhanbariDepartment of Nanotechnology, Faculty of Chemistry, Urmia University, Urmia, Iran.
Fatemeh AhourDepartment of Nanotechnology, Faculty of Chemistry, Urmia University, Urmia, Iran. F.ahour@urmia.ac.ir.
Sajjad KeshipourDepartment of Nanotechnology, Faculty of Chemistry, Urmia University, Urmia, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The electrochemical and photochemical properties of graphene derivatives could be significantly improved by modifications in the chemical structure. Herein, reduced graphene oxide (RGO) was functionalized with L-arginine (L-Arg) by an amidation reaction between the support and amino acid. Deposition of a powerful ligand, L-Arg, on the optically active support generated an effective optical chemosensor for the determination of Cd(II), Co(II), Pb(II), and Cu(II). In addition, L-Arg-RGO was used as an electrode modifier to fabricate L-Arg-RGO modified glassy-carbon electrode (L-Arg-RGO/GCE) to be employed in the selective detection of Pb(II) ions by differential pulse anodic stripping voltammetry (DP-ASV). L-Arg-RGO/GCE afforded better results than the bare GCE, RGO/GCE, and L-Arg functionalized graphene quantum dot modified GCE. The nanostructure of RGO, modification by L-Arg, and homogeneous immobilization of resultant nanoparticles at the electrode surface are the reasons for outstanding results. The proposed electrochemical sensor has a wide linear range with a limit of detection equal to 0.06 nM, leading to the easy detection of Pb(II) in the presence of other cations. This research highlighted that RGO as a promising support of optical, and electrochemical sensors could be used in the selective, and sensitive determination of transition metals depends on the nature of the modifier. Moreover, L-Arg as an abundant amino acid deserves to perch on the support for optical, and electrochemical determination of transition metals.

Indexed as

GraphiteAmino AcidsArginineElectrochemical TechniquesLeadAmino AcidsArgininegraphene oxideGraphiteLead

Identifiers

PMID36371538
PMCPMC9653396

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.